Flavonolignans reduce the virulence of antibiotic-resistant bacterial strains

Flavonolignans reduce the virulence of antibiotic-resistant bacterial strains
Strain of Staphylococcus aureus bacteria taken from a vancomycin intermediate resistant culture (VISA). Credit: By Content Providers(s): CDC/ Matthew J. Arduino, DRPHPhoto Credit: Janice Haney Carr - This media comes from the Centers for Disease Control and Prevention's Public Health Image Library (PHIL), with identification number #11157. Public Domain, commons.wikimedia.org/w/index.php?curid=7469288

Antibiotic resistance is currently a serious health problem. Since the discovery of new antibiotics no longer seems to be a sufficient tool in the fight against multidrug-resistant infections, adjuvant therapy is gaining importance as well as reducing bacterial virulence. Silymarin can be found in milk thistle and is a complex of flavonolignans known for its broad spectrum of biological activities, including its ability to modulate drug resistance in cancer.

Infections by Staphylococcus aureus cause severe diseases with high morbidity and mortality. One alternative to antibiotics is , where the mechanism of resistance is specifically inhibited, and the previously ineffective antibiotic regains its antimicrobial effects.

Flavonolignans have shown promising potential in this treatment approach. Authors of a recent study published in Biomedicine & Pharmacotherapy focused on the ability of flavonolignans to inhibit intercellular bacterial communication and inhibit bacterial cell adhesion to the surface.

Researchers from the University of Chemistry and Technology in Prague found that in particular, optically pure flavonolignans have great potential as adjunct therapeutics in the control of Staphylococcus aureus infections. Flavonolignans have no or negligible toxicity, and have no antibiotic activity of their own, precluding the development of resistance.

Flavonolignans have been part of the human diet for centuries, and have no . Numerous studies have demonstrated that flavonolignans have potent anticancer effects, and can restore the susceptibility of drug-resistant cancer cell lines. The research paper also highlights the need for the use of pure stereomers in the evaluation of biological activities.

"More attention should be paid to these compounds as they show promise for adjuvant therapies and reduce the virulence of antibiotic-resistant bacterial strains," says Jan Lipov, Ph.D.

More information: Kateřina Holasová et al, Flavonolignans from silymarin modulate antibiotic resistance and virulence in Staphylococcus aureus, Biomedicine & Pharmacotherapy (2022). DOI: 10.1016/j.biopha.2022.112806

Citation: Flavonolignans reduce the virulence of antibiotic-resistant bacterial strains (2022, November 2) retrieved 2 February 2023 from https://phys.org/news/2022-11-flavonolignans-virulence-antibiotic-resistant-bacterial-strains.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

The new compound that destroys the MRSA superbug


Feedback to editors